Evogene Ltd.
Hedge Funds Holdings
Last updated:
Evogene Ltd.‘s stocks are currently a part of 16 hedge funds’ portfolios, which represents 0.93% of the total amount of its stocks outstanding. This makes up a total of 384.29K shares of Evogene Ltd.. Compared to the previous quarter, the number fell by -64.68% or -703.77K shares fewer. As for the holding position changes, 31.25% (5) of current hedge fund investors increased the number of shares held, 25% (4) of current holders sold a part of the shares held, and 18.75% (3) closed the holdings completely. 2 hedge funds are new holders of Evogene Ltd. stock in Q1 2023, it is 12.5% of total holders.
Hedge funds holding Evogene Ltd. (Q2 2018 – Q1 2023)
| Q2 2018 | 23 |
|---|---|
| Q3 2018 | 23 |
| Q4 2018 | 23 |
| Q1 2019 | 21 |
| Q2 2019 | 17 |
| Q3 2019 | 17 |
| Q4 2019 | 15 |
| Q1 2020 | 15 |
| Q2 2020 | 16 |
| Q3 2020 | 17 |
| Q4 2020 | 33 |
| Q1 2021 | 43 |
| Q2 2021 | 41 |
| Q3 2021 | 37 |
| Q4 2021 | 41 |
| Q1 2022 | 36 |
| Q2 2022 | 27 |
| Q3 2022 | 23 |
| Q4 2022 | 25 |
| Q1 2023 | 16 |
Hedge funds changes in Evogene Ltd. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 7 | 3 | 3 | 9 |
|---|---|---|---|---|---|
| Q3 2018 | 0 | 9 | 3 | 0 | 11 |
| Q4 2018 | 2 | 5 | 4 | 2 | 10 |
| Q1 2019 | 1 | 7 | 5 | 3 | 5 |
| Q2 2019 | 1 | 3 | 6 | 5 | 2 |
| Q3 2019 | 2 | 3 | 3 | 1 | 8 |
| Q4 2019 | 0 | 1 | 7 | 2 | 5 |
| Q1 2020 | 1 | 4 | 2 | 1 | 7 |
| Q2 2020 | 4 | 3 | 4 | 3 | 2 |
| Q3 2020 | 8 | 4 | 5 | 7 | -7 |
| Q4 2020 | 20 | 7 | 4 | 4 | -2 |
| Q1 2021 | 18 | 16 | 5 | 8 | -4 |
| Q2 2021 | 6 | 13 | 18 | 8 | -4 |
| Q3 2021 | 3 | 8 | 20 | 7 | -1 |
| Q4 2021 | 9 | 12 | 11 | 5 | 4 |
| Q1 2022 | 2 | 10 | 12 | 7 | 5 |
| Q2 2022 | 2 | 4 | 13 | 11 | -3 |
| Q3 2022 | 2 | 7 | 4 | 6 | 4 |
| Q4 2022 | 6 | 4 | 7 | 3 | 5 |
| Q1 2023 | 2 | 5 | 4 | 3 | 2 |
Hedge funds changes in Evogene Ltd. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 1,132,000 | 1,528,000 |
| Q2 2021 | 722,000 | 879,000 |
| Q3 2021 | 238,000 | 449,000 |
| Q4 2021 | 14,000 | 361,000 |
| Q1 2022 | 25,000 | 187,000 |
| Q2 2022 | 31,000 | 28,000 |
| Q3 2022 | 19,000 | 23,000 |
| Q4 2022 | 6,720 | 14,210 |
| Q1 2023 | 36,540,000 | 0 |